Compounds for the treatment of inflammatory disorders
This invention relates to compounds of the Formula (I): (Chemical formula should be inserted here as it appears on abstract in paper form) (I) or a pharmaceutically acceptable salt, solvate or isomer thereof, which can be useful for the treatment of diseases or conditions mediated by MMPs, ADAMs, TACE, aggrecanase, TNF—or combinations thereof.
Merck Sharp & Dohme Corp.
C A A A A A A A A A A A A
C07D A61P A61P A61P A61P A61P A61P A61P A61P A61P A61P A61P A61P
inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional
Guowei Vinay Judson E. De-Yi Liping Janeta Bandarpalle B. Brian J. Luke M. Arshad Robert Dansu Kristin E. Seong Heon Aneta Maria Michael K. C. Ling Razia K. Chaoyang Joseph A. Wensheng
Zhou Girijavallabhan Richard Yang Yang Popovici-Muller Shankar Lavey Fire Siddiqui Feltz Li Rosner Kim Kosinski Wong Tong Rizvi Dai Kozlowski Yu